Laurie A. Scheiner

Array ( [id] => 1202114 [patent_doc_number] => 06719981 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-13 [patent_title] => 'Stable, attenuated rabies virus mutants and live vaccines thereof' [patent_app_type] => B1 [patent_app_number] => 09/856653 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2983 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/719/06719981.pdf [firstpage_image] =>[orig_patent_app_number] => 09856653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1366800 [patent_doc_number] => 06562350 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Combined vaccine against both HAV and measles virus and method of producing it' [patent_app_type] => B1 [patent_app_number] => 09/831752 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7545 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562350.pdf [firstpage_image] =>[orig_patent_app_number] => 09831752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869520 [patent_doc_number] => 20030082209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines' [patent_app_type] => new [patent_app_number] => 09/900112 [patent_app_country] => US [patent_app_date] => 2001-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 43759 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082209.pdf [firstpage_image] =>[orig_patent_app_number] => 09900112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416362 [patent_doc_number] => 06525178 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-25 [patent_title] => 'PGC-1, a novel brown fat PPARgamma coactivator' [patent_app_type] => B2 [patent_app_number] => 09/900236 [patent_app_country] => US [patent_app_date] => 2001-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 37586 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/525/06525178.pdf [firstpage_image] =>[orig_patent_app_number] => 09900236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6225284 [patent_doc_number] => 20020004477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-10 [patent_title] => 'Therapeutic administration of a modified alpha1 proteinase inhibitor' [patent_app_type] => new [patent_app_number] => 09/899500 [patent_app_country] => US [patent_app_date] => 2001-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4595 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 280 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20020004477.pdf [firstpage_image] =>[orig_patent_app_number] => 09899500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6541814 [patent_doc_number] => 20020110565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Viral vectors having enhanced effectiveness with reduced virulence' [patent_app_type] => new [patent_app_number] => 09/887295 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3755 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20020110565.pdf [firstpage_image] =>[orig_patent_app_number] => 09887295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1465903 [patent_doc_number] => 06458363 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'Method to produce inactivated w/o emulsion adjuvated vaccines' [patent_app_type] => B1 [patent_app_number] => 09/868818 [patent_app_country] => US [patent_app_date] => 2001-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4475 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458363.pdf [firstpage_image] =>[orig_patent_app_number] => 09868818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6063298 [patent_doc_number] => 20020031761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Binding moieties for human parvovirus B19' [patent_app_type] => new [patent_app_number] => 09/881276 [patent_app_country] => US [patent_app_date] => 2001-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8381 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20020031761.pdf [firstpage_image] =>[orig_patent_app_number] => 09881276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1541398 [patent_doc_number] => 06372223 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Influenza virus vaccine composition' [patent_app_type] => B1 [patent_app_number] => 09/787322 [patent_app_country] => US [patent_app_date] => 2001-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5429 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372223.pdf [firstpage_image] =>[orig_patent_app_number] => 09787322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1415396 [patent_doc_number] => 06506386 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Vaccine comprising an iscom consisting of sterol and saponin which is free of additional detergent' [patent_app_type] => B1 [patent_app_number] => 09/744800 [patent_app_country] => US [patent_app_date] => 2001-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4990 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506386.pdf [firstpage_image] =>[orig_patent_app_number] => 09744800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1234532 [patent_doc_number] => 06689366 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-10 [patent_title] => 'Synthetic virus like particles with heterologous epitopes' [patent_app_type] => B1 [patent_app_number] => 09/857337 [patent_app_country] => US [patent_app_date] => 2001-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 6005 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689366.pdf [firstpage_image] =>[orig_patent_app_number] => 09857337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6778744 [patent_doc_number] => 20030049825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Nervous necrosis virus protein' [patent_app_type] => new [patent_app_number] => 09/867932 [patent_app_country] => US [patent_app_date] => 2001-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3186 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049825.pdf [firstpage_image] =>[orig_patent_app_number] => 09867932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936081 [patent_doc_number] => 20020061581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the same' [patent_app_type] => new [patent_app_number] => 09/865483 [patent_app_country] => US [patent_app_date] => 2001-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2923 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061581.pdf [firstpage_image] =>[orig_patent_app_number] => 09865483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846373 [patent_doc_number] => 20030165540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Sentinel virus II' [patent_app_type] => new [patent_app_number] => 09/849729 [patent_app_country] => US [patent_app_date] => 2001-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11258 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165540.pdf [firstpage_image] =>[orig_patent_app_number] => 09849729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1017640 [patent_doc_number] => 06890532 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-10 [patent_title] => 'Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods' [patent_app_type] => utility [patent_app_number] => 09/848832 [patent_app_country] => US [patent_app_date] => 2001-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5676 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890532.pdf [firstpage_image] =>[orig_patent_app_number] => 09848832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 773269 [patent_doc_number] => 07001760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-21 [patent_title] => 'Hepatitis B virus vectors for gene therapy' [patent_app_type] => utility [patent_app_number] => 09/837297 [patent_app_country] => US [patent_app_date] => 2001-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 7905 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/001/07001760.pdf [firstpage_image] =>[orig_patent_app_number] => 09837297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6778749 [patent_doc_number] => 20030049830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Herpes virus complementing cell line' [patent_app_type] => new [patent_app_number] => 10/257229 [patent_app_country] => US [patent_app_date] => 2002-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8101 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049830.pdf [firstpage_image] =>[orig_patent_app_number] => 10257229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 944022 [patent_doc_number] => 06967075 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-22 [patent_title] => 'HCV replicase complexes' [patent_app_type] => utility [patent_app_number] => 09/828034 [patent_app_country] => US [patent_app_date] => 2001-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9992 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/967/06967075.pdf [firstpage_image] =>[orig_patent_app_number] => 09828034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6361192 [patent_doc_number] => 20020058620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Cell growth regulation system' [patent_app_type] => new [patent_app_number] => 09/822540 [patent_app_country] => US [patent_app_date] => 2001-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6492 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058620.pdf [firstpage_image] =>[orig_patent_app_number] => 09822540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6901388 [patent_doc_number] => 20010022971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-20 [patent_title] => 'IBD-associated microbial nucleic acid molecules' [patent_app_type] => new [patent_app_number] => 09/820576 [patent_app_country] => US [patent_app_date] => 2001-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14657 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20010022971.pdf [firstpage_image] =>[orig_patent_app_number] => 09820576 [rel_patent_id] =>[rel_patent_doc_number] =>)